Twenty four child-bearing aged women and 26 postmenopausal women were studied for the serum estradiol (E_2) level, total cholesterol(T-CH), HDL-CH and HDL subfractions, None of them is smooker or drinker.
RESULTS:Of the 109 menopausal women,anxiety symptom was found in 69 cases(63%),with the mean total SDSS score of 7.55±2.61,obviously higher than the results of those without anxiety symptom(40 cases,3.39±0.94)(t=2.238,P< 0.05).
METHODS: Totally 50 women with menopausal osteoporosis were selected from the First Hospital Affiliated to China Medical University from February 2002 to May 2004. Another 50 menopause women with normal items in health examination were also selected as control group at synchronization.
METHODS: ①Totally 154 climacteric women,who were inpatients or outpatients and aged 42-55 years,were selected from Puning Overseas Chinese Hospital from May 2003 to October 2005. And 39 healthy women who conducted health examinations in same hospital simultaneously were selected as control group,aged 41-59 years.
③Physical and mental symptoms of climacteric women were assessed with Common Physical and Mental Symptoms Scale,modified by Professor Peng Xie-ying,Xiangya Hospital of Central South University and included 14 items: worry,depression,paresthesia of skin,dizziness,impaired concentration,cool extremity,multidream and restless sleep,lumbago and backache,hypochondriasis,languor and debilitation,tinnitus,easy to excite,difficulty falling asleep and memory decrease.
The Effects of Estrogen on Indices of Skeletal Muscle Tissue Damage after Eccentric Exercise in Postmenopausal Women
This study examined if estrogen (E) usage (in the form of hormone replacement therapy (HRT)) has a protective effect on skeletal muscle damage in postmenopausal women.
Nine postmenopausal women (age 55.2 ± 9.9 [mean ± SD]) performed two exercise sessions at 70% of their maximal heart rate on HRT (E-HI) and without HRT (E-LO; following a 28-45 day HRT washout).
Recent studies with PET based measurements of blood flow target specifically the endothelial dependent coronary vasomotion and revealed abnormalities in chronic smokers and in postmenopausal women, that is, after estrogen withdrawal.
The single application of estradiol in postmenopausal women with symptomatic coronary heart disease has an antiischemic effect, which seems to be mainly related to the relaxation of the vascular smooth muscle.
Hormone replacement therapy and its influence on AT-III activity in climacteric women
Accordingly, persistent beclin 1 expression was found in granulosa-lutein cells under either physiological (i.e., CL of pregnancy) or pathological (irregularly regressing CL in climacteric women) conditions involving prolonged CL life span.
Twelve climacteric women underwent full assessment before and 1 year after treatment with a 50 mg subcutaneous estradiol implant +5 mg norethisterone for 7 days per month.
Women at risk, such as multiparous and climacteric women, were selected from the community (n= 200) and health-care centers (n= 200) and interviewed about inappropriate urine loss in the past 12 months, using a structured and pretested questionnaire.
Urodynamics in Climacteric Women with Urinary Incontinence: Correlation with Route of Delivery